Showing 1 - 3 results of 3 for search 'RISK ANALYSIS AND HAZARD COMMUNICATION', query time: 1.33s Refine Results
  1. 1
    Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
    “... that previous users do not restart ACEI/ARB despite ongoing indications. We sought to determine the risk...”
    Get full text
    Article
  2. 2
    Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results
    “... 0.46 to 0.70, vs. TORCH trial risk ratio 0.85, 95% confidence interval 0.74 to 0.97). For the analysis...”
    Get full text
    Article
  3. 3
    Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study [version 1; peer review: 2 approved]
    “... ACEI were at increased risk of S. aureus infection, comparing them to users of Angiotensin II Receptor...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search